Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, June 22, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, June 21, 2017
[ 01:45 PM ] - United States, WOPRAI
[ 01:45 PM ] - United States, WOPRAI
[ 01:45 PM ] - United States, WOPRAI
[ 01:45 PM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, June 20, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, June 19, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Carter Gould Upgraded (BIIB) to Hold on, Jun 19th, 2017
Published on 2024-10-25 21:23:28 - WOPRAI, Carter Gould
Carter Gould of UBS, Upgraded "Biogen Inc." (BIIB) to Hold on, Jun 19th, 2017.
Carter has made no other calls on BIIB in the last 4 months.
There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, all agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Thursday, March 16th, 2017
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $305 on, Thursday, March 16th, 2017
